A unanimous U.S. Supreme Court that often is skeptical of patents embraced a key seed patent last week in the case of a Monsanto Co. soybean variety that was being replicated by savvy farmers.
The decision in the closely watched Bowman v. Monsanto Co. may have its biggest impact in biotechnology, where self-replicating techniques often are used in research as well as commerce. Language in the decision could invite more patent infringement claims in that field, said Kenyon & Kenyon partner Patrice Jean, although she added, "I don’t think the court meant to prevent researchers from continuing their research."
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
